Filing Details

Accession Number:
0001209191-22-059718
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-05 16:46:42
Reporting Period:
2022-12-01
Accepted Time:
2022-12-05 16:46:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
883107 Nanophase Technologies Corp NANX Miscellaneous Primary Metal Products (3390) 363687863
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184478 Jess Jankowski 1319 Marquette Drive
Romeoville IL 60446
President, Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-01 1,000 $0.42 60,000 No 4 M Direct
Common Stock Disposition 2022-12-01 1,000 $1.50 59,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (right to purchase) Disposition 2022-12-01 1,000 $0.42 27,126 $0.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,126 2014-02-14 2023-02-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect Spouse's IRA
Common Stock 59,000 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Common Stock (right to purchase) $0.52 2015-02-13 2024-02-13 90,000 90,000 Direct
Common Stock Common Stock (right to purchase) $0.44 2016-02-18 2025-02-18 81,000 81,000 Direct
Common Stock Common Stock (right to purchase) $0.42 2017-02-23 2026-02-23 69,000 69,000 Direct
Common Stock Common Stock (right to purchase) $0.68 2018-02-21 2027-02-21 81,000 81,000 Direct
Common Stock Common Stock (right to purchase) $0.82 2019-05-23 2028-05-23 90,000 90,000 Direct
Common Stock Common Stock (right to purchase) $0.51 2020-05-22 2029-05-22 16,500 16,500 Direct
Common Stock Common Stock (right to purchase) $0.45 2021-06-18 2027-06-18 90,000 90,000 Direct
Common Stock Common Stock (right to purchase) $4.17 2022-12-28 2028-12-28 90,000 90,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-02-13 90,000 90,000 Direct
2025-02-18 81,000 81,000 Direct
2026-02-23 69,000 69,000 Direct
2027-02-21 81,000 81,000 Direct
2028-05-23 90,000 90,000 Direct
2029-05-22 16,500 16,500 Direct
2027-06-18 90,000 90,000 Direct
2028-12-28 90,000 90,000 Direct
Footnotes
  1. These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
  2. If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released. In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days. Typically, this would reopen trading in early-to-mid March, through March 24th. The next blackout period would begin on March 25th, etc.
  3. The price reported is a weighted average price. These shares were sold through multiple transactions, two in all, at prices ranging from $1.50 to $1.51.
  4. These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
  5. Subject to certain restrictions, beginning on this date, options vest in three equal installments.
  6. Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments.
  7. Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.